Literature DB >> 16322244

Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.

Elena I Deryugina1, Andries Zijlstra, Juneth J Partridge, Tatyana A Kupriyanova, Mark A Madsen, Thales Papagiannakopoulos, James P Quigley.   

Abstract

The human tumor/chick embryo model involving grafting of human HT-1080 fibrosarcoma cells on the chorioallantoic membrane was used in conjunction with quantitative real-time Alu PCR to select in vivo a pair of isogenic cell lines (HT-hi/diss and HT-lo/diss), dramatically differing in their ability to disseminate from the primary tumor (i.e., intravasate into the chorioallantoic membrane vasculature and metastasize to the lungs). During an immunohistochemical time course study, HT-hi/diss cells were sequentially visualized having escaped from the primary tumors, engaged with the blood vessels, and eventually observed inside the chorioallantoic membrane capillaries, thus reflecting early intravasating events. In contrast, HT-lo/diss cells seemed restricted to their primary tumor. Importantly, after i.v. inoculation, both variants arrested, extravasated, and proliferated in host tissues with similar efficiencies, highlighting that the observed earlier events at the periphery of the primary tumor could account for their differential dissemination. In a mechanistic probing of these events, we determined that HT-hi/diss intravasation was sensitive to a broad-range matrix metalloproteinase (MMP) inhibitor. To analyze the possible role of individual MMPs, membrane-bound MMP-14 and secreted MMP-9 were individually down-regulated in HT-hi/diss cells with their corresponding small interfering RNAs. Despite efficient down-regulation of MMP-14, neither intravasation nor metastasis of HT-hi/diss cells was affected significantly. However, a substantial down-regulation of MMP-9 was accompanied by a surprising 3-fold increase in intravasation and metastasis. The results emphasize a rising awareness that targeting certain MMPs might result in an enhanced malignancy, exemplified herein at the intravasation level as this step of the metastatic cascade is dissected and quantified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322244     DOI: 10.1158/0008-5472.CAN-05-2228

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.

Authors:  M Cecilia Subauste; Tatyana A Kupriyanova; Erin M Conn; Veronica C Ardi; James P Quigley; Elena I Deryugina
Journal:  Clin Exp Metastasis       Date:  2009-10-20       Impact factor: 5.150

2.  Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane.

Authors:  Maurice Balke; Anna Neumann; Christian Kersting; Konstantin Agelopoulos; Carsten Gebert; Georg Gosheger; Horst Buerger; Martin Hagedorn
Journal:  BMC Res Notes       Date:  2010-03-04

Review 3.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Matrix Biol       Date:  2015-04-22       Impact factor: 11.583

4.  Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma.

Authors:  Elena I Deryugina; William B Kiosses
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

5.  Quantitative analysis of cancer metastasis using an avian embryo model.

Authors:  Trenis D Palmer; John Lewis; Andries Zijlstra
Journal:  J Vis Exp       Date:  2011-05-30       Impact factor: 1.355

6.  Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

Authors:  Rebecca Brooks; Nora Kizer; Loan Nguyen; Atthapon Jaishuen; Karolyn Wanat; Elizabeth Nugent; Perry Grigsby; Jenifer E Allsworth; Janet S Rader
Journal:  Gynecol Oncol       Date:  2009-11-10       Impact factor: 5.482

7.  Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.

Authors:  Swadesh K Das; Sujit K Bhutia; Upneet K Sokhi; Belal Azab; Zhao-Zhong Su; Habib Boukerche; Talha Anwar; Erika L Moen; Devasis Chatterjee; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2012-10-11       Impact factor: 12.701

8.  Chick ex ovo culture and ex ovo CAM assay: how it really works.

Authors:  Daniel S Dohle; Susanne D Pasa; Sebastian Gustmann; Markus Laub; Josef H Wissler; Herbert P Jennissen; Nicole Dünker
Journal:  J Vis Exp       Date:  2009-11-30       Impact factor: 1.355

9.  A novel mode of intervention with serine protease activity: targeting zymogen activation.

Authors:  Grant E Blouse; Kenneth A Bøtkjaer; Elena Deryugina; Aleksandra A Byszuk; Janni M Jensen; Kim K Mortensen; James P Quigley; Peter A Andreasen
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

10.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.